Published in Transpl Int on April 01, 1989
Primer on certain elements of medical decision making. N Engl J Med (1975) 6.28
Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res (2001) 3.89
Aortic dissection: a comparative study of diagnosis with spiral CT, multiplanar transesophageal echocardiography, and MR imaging. Radiology (1996) 2.38
Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments]. Kidney Int (1999) 2.13
Erythropoietin and iron. Clin Nephrol (1997) 2.02
Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke (1998) 1.95
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene (2009) 1.87
Androgen receptor: an overview. Crit Rev Eukaryot Gene Expr (1995) 1.81
Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol (1998) 1.78
Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb). Br J Haematol (2001) 1.68
Hsp70 chaperone machines. Adv Protein Chem (2001) 1.67
Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J (2000) 1.66
The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am J Transplant (2009) 1.60
Severe nephrotic syndrome in a patient with Schönlein-Henoch purpura: complete remission after cyclosporin A. Nephrol Dial Transplant (1997) 1.60
Immunoglobulin light chains modulate polymorphonuclear leucocyte apoptosis. Eur J Clin Invest (2003) 1.57
Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age. J Pediatr Endocrinol Metab (2002) 1.55
Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant (1998) 1.53
Bag-1M accelerates nucleotide release for human Hsc70 and Hsp70 and can act concentration-dependent as positive and negative cofactor. J Biol Chem (2001) 1.52
In vitro detection of C4d-fixing HLA alloantibodies: associations with capillary C4d deposition in kidney allografts. Am J Transplant (2007) 1.52
Treatment of renal anemia with recombinant human erythropoietin. Am J Nephrol (1989) 1.50
Practical guidelines for the use of NESP in treating renal anaemia. Nephrol Dial Transplant (2001) 1.47
Tissue-interface pressures on three different support-surfaces for trauma patients. Injury (2005) 1.47
Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia. Kidney Int (2006) 1.47
High prevalence of hyperhomocysteinemia in critically ill patients. Crit Care Med (2000) 1.46
Cyclooxygenase metabolites mediate glomerular monocyte chemoattractant protein-1 formation and monocyte recruitment in experimental glomerulonephritis. Kidney Int (1999) 1.45
Binding specificity of Escherichia coli trigger factor. Proc Natl Acad Sci U S A (2001) 1.45
Adequacy of automated peritoneal dialysis with and without manual daytime exchange: A randomized controlled trial. Kidney Int (2006) 1.43
Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia. Wien Klin Wochenschr (2000) 1.42
Continuous arteriovenous haemoperfusion (CAVHP) for treatment of paraquat poisoning. Nephrol Dial Transplant (1992) 1.41
Gulliver G-100 - A new device to evaluate daily growth measurement in comparison with Harpenden stadiometer. Horm Res (1999) 1.40
European Council of Legal Medicine (ECLM) accreditation of forensic pathology services in Europe. Int J Legal Med (2014) 1.40
Routine molecular genotyping of HLA-B27 in spondyloarthropathies overcomes the obstacles of serological typing and reveals an increased B *2702 frequency in ankylosing spondylitis. J Rheumatol (1997) 1.39
IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity. Diabetologia (2003) 1.37
MRI findings in Hirayama's disease: flexion-induced cervical myelopathy or intrinsic motor neuron disease? J Neurol (1999) 1.36
The Nuclear Receptor Resource: a growing family. Nucleic Acids Res (1998) 1.34
Current concepts of molecular defence mechanisms operative during urinary tract infection. Eur J Clin Invest (2008) 1.32
Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERalpha mRNA. J Clin Endocrinol Metab (2000) 1.29
Effect of local low-dose thrombolysis on clinical outcome in acute embolic renal artery occlusion. Radiology (1993) 1.27
The kisspeptin system of the human hypothalamus: sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B neurons. Eur J Neurosci (2010) 1.27
Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med (2000) 1.23
The association of rhinoviruses with lower respiratory tract disease in hospitalized patients. J Med Virol (1986) 1.23
Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations. Clin Pharmacokinet (1993) 1.22
Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant (2001) 1.20
Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. J Clin Invest (1997) 1.19
A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol (1998) 1.19
Urinary tract infection in renal transplant recipients. Eur J Clin Invest (2008) 1.16
Central venous catheter-induced delayed hydrothorax via progressive erosion of central venous wall. Minerva Anestesiol (2010) 1.15
Detectability and detection rate of acute cerebral hemisphere infarcts on CT and diffusion-weighted MRI. Neuroradiology (2000) 1.14
Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy. Clin Pharmacokinet (2000) 1.13
Immune dysfunction in uremia. Kidney Int Suppl (1997) 1.13
Human pituitary gonadotropin index. I. Standardized LRH test criteria for evaluation of functional amenorrhea. J Clin Endocrinol Metab (1975) 1.12
Is absorption of high-dose oral iron sufficient in peritoneal dialysis patients? Perit Dial Int (2001) 1.11
Middle cerebral artery (MCA) susceptibility sign at susceptibility-based perfusion MR imaging: clinical importance and comparison with hyperdense MCA sign at CT. Radiology (2000) 1.11
Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int (1993) 1.11
ERK5 signalling in prostate cancer promotes an invasive phenotype. Br J Cancer (2011) 1.10
Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. J Am Soc Nephrol (1998) 1.10
Effectiveness of treatments of depression in older ambulatory patients. Arch Intern Med (1998) 1.10
Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology (2000) 1.10
Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol (2000) 1.09
Common errors in diagnosis and management of urinary tract infection. I: pathophysiology and diagnostic techniques. Nephrol Dial Transplant (1999) 1.08
TNF alpha induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int (1993) 1.08
Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography. Endoscopy (2002) 1.07
Are needle-free injections a useful alternative for growth hormone therapy in children? Safety and pharmacokinetics of growth hormone delivered by a new needle-free injection device compared to a fine gauge needle. J Pediatr Endocrinol Metab (2003) 1.06
Similarities in the control of the speech articulators and the limbs: kinematics of tongue dorsum movement in speech. J Exp Psychol Hum Percept Perform (1983) 1.06
Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. Kidney Int Suppl (2001) 1.06
New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography. J Am Soc Nephrol (1998) 1.05
The first three years of the Swiss Neuropaediatric Stroke Registry (SNPSR): a population-based study of incidence, symptoms and risk factors. Neuropediatrics (2005) 1.04
ESPEN Guidelines on Enteral Nutrition: Adult renal failure. Clin Nutr (2006) 1.04
Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: the German BABYDIAB study. Diabetologia (1999) 1.03
Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology (2001) 1.02
The soluble leptin receptor is crucial for leptin action: evidence from clinical and experimental data. Int J Obes Relat Metab Disord (2003) 1.02
Kinetics of ceftazidime during plasmapheresis. Eur J Clin Pharmacol (1987) 1.02
The human forebrain has discrete estrogen receptor alpha messenger RNA expression: high levels in the amygdaloid complex. Neuroscience (2000) 1.01
Transcription termination factor Rho is essential for Micrococcus luteus. J Bacteriol (1997) 1.00
Plasma level monitoring of mitotane (o,p'-DDD) and its metabolite (o,p'-DDE) during long-term treatment of Cushing's disease with low doses. Eur J Clin Pharmacol (1991) 0.99
Gonadotropin-releasing hormone neurons express estrogen receptor-beta. J Clin Endocrinol Metab (2007) 0.99
Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain. Neuroscience (2003) 0.99
The human brain has distinct regional expression patterns of estrogen receptor alpha mRNA isoforms derived from alternative promoters. J Neurochem (2000) 0.98
New insights into the regulation of iron homeostasis. Eur J Clin Invest (2006) 0.98
Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol (1996) 0.97
Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects. Transplantation (1995) 0.97
Mechanosensitivity of voltage-gated calcium currents in rat anterior pituitary cells. J Physiol (1994) 0.97
Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor i receptor (IGF1R) mutation: implications for a gene dosage effect of the human IGF1R. J Clin Endocrinol Metab (2006) 0.97
Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int (1997) 0.96
A new mouse model of immune-mediated podocyte injury. Kidney Int (2007) 0.96
Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations. Am J Transplant (2013) 0.96
Tamm-Horsfall protein: a multilayered defence molecule against urinary tract infection. Eur J Clin Invest (2005) 0.96
Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. Kidney Int (1997) 0.96
Treatment of pelvic abscesses: value of one-step sonographically guided transrectal needle aspiration and lavage. AJR Am J Roentgenol (1995) 0.96
Surgical removal and immediate reattachment of coronal fragment embedded in lip. Dent Traumatol (2006) 0.96
Pharmacokinetics of gabapentin in subjects with various degrees of renal function. Clin Pharmacol Ther (1994) 0.96
Iron and infection. Kidney Int Suppl (1999) 0.95
Immune-mediated mesangial cell injury--biosynthesis and function of prostanoids. Kidney Int (1990) 0.95
Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain. Arthritis Rheum (1996) 0.94
Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device. Horm Res (1999) 0.93
Mediator systems in a passive model of in situ immune complex glomerulonephritis. Role for complement, polymorphonuclear granulocytes and monocytes. Lab Invest (1986) 0.93
Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid beta1-42 and beta1-40 immunoreactivity profiles. Neurobiol Dis (2000) 0.93
Human pituitary gonadotrophin index. II LHRH test and clomiphene response before and after LHRH stimulation. Clin Endocrinol (Oxf) (1976) 0.92
Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions. J Am Soc Nephrol (1995) 0.92
Quality of water used for haemodialysis: bacteriological and chemical parameters. Nephrol Dial Transplant (1999) 0.92